Prostate-specific antigen (PSA) velocity: a test of controversial benefit in the era of increased prostate cancer screening.
作者信息
Borofsky Michael S, Makarov Danil V
机构信息
Department of Urology, New York University School of Medicine, New York, NY 10016, USA.
出版信息
Asian J Androl. 2011 Jul;13(4):614-5. doi: 10.1038/aja.2011.38. Epub 2011 May 2.
Abstract
摘要
相似文献
1
Prostate-specific antigen (PSA) velocity: a test of controversial benefit in the era of increased prostate cancer screening.前列腺特异性抗原（PSA）速率：在前列腺癌筛查增加的时代，一项益处存争议的检测。
Asian J Androl. 2011 Jul;13(4):614-5. doi: 10.1038/aja.2011.38. Epub 2011 May 2.
2
National trends in the epidemiology of prostate cancer, 1973 to 1994: evidence for the effectiveness of prostate-specific antigen screening.1973年至1994年前列腺癌流行病学的全国趋势：前列腺特异性抗原筛查有效性的证据
Urology. 1998 Sep;52(3):444-8; discussion 448-9. doi: 10.1016/s0090-4295(98)00242-8.
3
Population screening for prostate cancer and emerging concepts for young men.前列腺癌的人群筛查及针对年轻男性的新观念
Clin Prostate Cancer. 2003 Sep;2(2):87-97. doi: 10.3816/cgc.2003.n.015.
4
Prostate-specific antigen velocity at low prostate-specific antigen levels as screening tool for prostate cancer: results of second screening round of ERSPC (ROTTERDAM).低前列腺特异性抗原水平下的前列腺特异性抗原变化率作为前列腺癌筛查工具：欧洲前列腺癌筛查随机对照研究（鹿特丹）第二轮筛查结果
Urology. 2004 Feb;63(2):309-13; discussion 313-5. doi: 10.1016/j.urology.2003.09.083.
5
Clinical characteristics of prostate cancer in Japanese men in the eras before and after serum prostate-specific antigen testing.血清前列腺特异性抗原检测前后时代日本男性前列腺癌的临床特征
Int J Urol. 2005 Jul;12(7):662-7. doi: 10.1111/j.1442-2042.2005.01113.x.
6
Screening for prostate cancer with the prostate-specific antigen test: a review of current evidence.用前列腺特异性抗原检测进行前列腺癌筛查：当前证据回顾。
JAMA. 2014 Mar 19;311(11):1143-9. doi: 10.1001/jama.2014.2085.
7
[Prostate cancer and prostate specific antigen screening].[前列腺癌与前列腺特异性抗原筛查]
Minerva Med. 2004 Feb;95(1):25-34.
9
Men's preferences and trade-offs for prostate cancer screening: a discrete choice experiment.男性对前列腺癌筛查的偏好与权衡：一项离散选择实验
Health Expect. 2015 Dec;18(6):3123-35. doi: 10.1111/hex.12301. Epub 2014 Nov 10.
10
Unravelling the prostate-specific antigen controversy: a West of Scotland perspective.揭开前列腺特异性抗原争议的面纱：苏格兰西部的观点。
Scott Med J. 2014 May;59(2):126-9. doi: 10.1177/0036933014528618. Epub 2014 Mar 28.
引用本文的文献
1
A novel equation and nomogram including body weight for estimating prostate volumes in men with biopsy-proven benign prostatic hyperplasia.一种新型方程和列线图，包括体重，用于估算经活检证实的良性前列腺增生男性的前列腺体积。
Asian J Androl. 2012 Sep;14(5):703-7. doi: 10.1038/aja.2012.31. Epub 2012 Jul 9.
本文引用的文献
1
Measuring the importance of PSA velocity.测量前列腺特异抗原速度的重要性。
J Natl Cancer Inst. 2011 Mar 16;103(6):454-61. doi: 10.1093/jnci/djr086. Epub 2011 Mar 10.
2
An empirical evaluation of guidelines on prostate-specific antigen velocity in prostate cancer detection.前列腺特异性抗原速度指南在前列腺癌检测中的实证评估。
J Natl Cancer Inst. 2011 Mar 16;103(6):462-9. doi: 10.1093/jnci/djr028. Epub 2011 Feb 24.
3
NCCN clinical practice guidelines in oncology: prostate cancer early detection.美国国立综合癌症网络（NCCN）肿瘤学临床实践指南：前列腺癌早期检测
J Natl Compr Canc Netw. 2010 Feb;8(2):240-62. doi: 10.6004/jnccn.2010.0016.
4
Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy.经直肠超声引导前列腺活检后泌尿系统并发症住院率升高。
J Urol. 2010 Mar;183(3):963-8. doi: 10.1016/j.juro.2009.11.043. Epub 2010 Jan 20.
5
Prostate cancer mortality in screen and clinically detected prostate cancer: estimating the screening benefit.筛查和临床检出前列腺癌的前列腺癌死亡率：估计筛查的获益。
Eur J Cancer. 2010 Jan;46(2):377-83. doi: 10.1016/j.ejca.2009.09.008. Epub 2009 Oct 3.
6
Prostate specific antigen best practice statement: 2009 update.前列腺特异性抗原最佳实践声明：2009年更新版
J Urol. 2009 Nov;182(5):2232-41. doi: 10.1016/j.juro.2009.07.093. Epub 2009 Sep 24.
7
Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005.前列腺特异性抗原筛查引入后的前列腺癌诊断与治疗：1986 - 2005年
J Natl Cancer Inst. 2009 Oct 7;101(19):1325-9. doi: 10.1093/jnci/djp278. Epub 2009 Aug 31.
8
Screening and prostate-cancer mortality in a randomized European study.一项欧洲随机研究中的筛查与前列腺癌死亡率
N Engl J Med. 2009 Mar 26;360(13):1320-8. doi: 10.1056/NEJMoa0810084. Epub 2009 Mar 18.
9
Active surveillance for prostate cancer: trials and tribulations.前列腺癌的主动监测：试验与磨难
World J Urol. 2008 Oct;26(5):437-42. doi: 10.1007/s00345-008-0330-8. Epub 2008 Sep 24.
10
Prostate-specific antigen (PSA) and PSA velocity for prostate cancer detection in men aged <50 years.前列腺特异性抗原（PSA）及PSA速率在50岁以下男性前列腺癌检测中的应用
BJU Int. 2007 Apr;99(4):753-7. doi: 10.1111/j.1464-410X.2006.06682.x. Epub 2007 Jan 19.
Zotero 插件